Innovation

Use of Agonists to Antagonize TLR4

University of Michigan
posted on 08/27/2010

Use of Agonists to Antagonize TLR4


Innovation Details
 

Detailed Description

UM File # 4366

Background
The Toll family of polypeptides is remarkably conserved across the taxonomic kingdoms, suggesting essential role in physiology. These peptides share homologous domains and signaling pathways, which are used to trigger inflammatory and immunological responses. However, the function of these proteins extends beyond host defense. As expressed on leukocytes, endothelial cells, and various parenchymal cells, Toll-like receptor 4 (TLR4) detects the products of microorganisms, which initiates signals leading to activation of NFKB, among other signaling that induce the expression of genes that incite inflammation and adaptive immunity. These responses sequester and clear microorganisms and heighten resistance of the host upon re-infection.

Technology Description
Researchers at the University of Michigan and another institution have developed methods and materials to modulate TLR activity in cells. In particular, CXCR4 binding agents may be administered to modulate the ability of TLRs to respond to agonists. These CXCR4 binding agents include anti-CXCR4 antibody and SDF-1 polypeptide to increase or decrease, respectively, TLR4 polypeptide activity in response to TLR agonist such as lipopolysaccahide, heparan sulfate, and viral nucleic acids.

Applications
• Modulation of TLR4 activity

Advantages
• Activity of TLR4 may be increased or decreased via use of different materials provided herein

File Number: 4366 


IP Protection

Patent Number(s): 11/813652

License Online

This innovation currently is not available for online licensing. Please contact Mutsumi Yoshida at University of Michigan for more information.

Request more info via email request more info
People

Case Manager:

Mutsumi Yoshida Mutsumi Yoshida

Innovations (73)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Martin Lehr, Osage University Partners

"iBridge is a great resource for entrepreneurs who are looking for technologies to license. Many premiere universities including Michigan, Columbia, MIT, Penn, and Harvard, participate in the iBridge program."  read more...